Literature DB >> 9155861

Selecting and using nebuliser equipment.

A H Kendrick1, E C Smith, R S Wilson.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9155861      PMCID： PMC1765870          DOI： 10.1136/thx.52.2008.s92

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  25 in total

1.  Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol.

Authors:  P Shah; L Dhurjon; T Metcalfe; J M Gibson
Journal:  BMJ       Date:  1992-01-04

2.  Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.

Authors:  J H Dennis; S C Stenton; J R Beach; A J Avery; E H Walters; D J Hendrick
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  Drug delivery from jet nebulisers.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

4.  Some factors influencing the efficiency of a jet nebuliser system.

Authors:  S W Smye; A Shaw; H M Norwood; J M Littlewood
Journal:  Clin Phys Physiol Meas       Date:  1990-05

5.  Migratory anisocoria--a novel clinical entity.

Authors:  F Samaniego; L S Newman
Journal:  Am Rev Respir Dis       Date:  1986-10

6.  Assessment of jet nebulisers for lung aerosol therapy.

Authors:  M M Clay; D Pavia; S P Newman; T Lennard-Jones; S W Clarke
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

7.  Is the flow rate used to drive a jet nebuliser clinically important?

Authors:  J G Douglas; M J Leslie; G K Crompton; I W Grant
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

8.  The importance of particle size in response to inhaled bronchodilators.

Authors:  P J Rees; T J Clark; F Morén
Journal:  Eur J Respir Dis Suppl       Date:  1982

9.  Evaluation of jet nebulisers for use with gentamicin solution.

Authors:  S P Newman; P G Pellow; M M Clay; S W Clarke
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

10.  Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers.

Authors:  S H Thomas; M J O'Doherty; C J Page; T O Nunan; N T Bateman
Journal:  Eur Respir J       Date:  1991-05       Impact factor: 16.671
View more
  11 in total

1.  Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.

Authors:  Haidong Huang; Paul Zarogoulidis; Sofia Lampaki; John Organtzis; Dimitris Petridis; Konstantinos Porpodis; Antonis Papaiwannou; Vasilis Karageorgiou; Georgia Pitsiou; Ioannis Kioumis; Wolfgang Hohenforst-Schmidt; Qiang Li; Kaid Darwiche; Lutz Freitag; Aggeliki Rapti; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 2.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

Review 3.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers.

Authors:  Amir Amani; Peter York; Henry Chrystyn; Brian J Clark
Journal:  AAPS PharmSciTech       Date:  2010-07-24       Impact factor: 3.246

5.  Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.

Authors:  Yu Lin; Rachel Yoon Kyung Chang; Warwick J Britton; Sandra Morales; Elizabeth Kutter; Hak-Kim Chan
Journal:  Int J Pharm       Date:  2018-09-14       Impact factor: 5.875

Review 6.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22

Review 7.  Clinical experimentation with aerosol antibiotics: current and future methods of administration.

Authors:  Paul Zarogoulidis; Ioannis Kioumis; Konstantinos Porpodis; Dionysios Spyratos; Kosmas Tsakiridis; Haidong Huang; Qiang Li; J Francis Turner; Robert Browning; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Drug Des Devel Ther       Date:  2013-10-02       Impact factor: 4.162

8.  Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.

Authors:  Paul Zarogoulidis; Ioannis Kioumis; Sofia Lampaki; John Organtzis; Konstantinos Porpodis; Dionysios Spyratos; Georgia Pitsiou; Dimitris Petridis; Athanasia Pataka; Haidong Huang; Qiang Li; Lonny Yarmus; Wolfgang Hohenforst-Schmidt; Nikolaos Pezirkianidis; Konstantinos Zarogoulidis
Journal:  Drug Des Devel Ther       Date:  2014-08-12       Impact factor: 4.162

9.  Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.

Authors:  Georgia Pitsiou; Paul Zarogoulidis; Dimitris Petridis; Ioannis Kioumis; Sofia Lampaki; John Organtzis; Konstantinos Porpodis; Antonis Papaiwannou; Theodora Tsiouda; Wolfgang Hohenforst-Schmidt; Stylianos Kakolyris; Konstantinos Syrigos; Haidong Huang; Qiang Li; J Francis Turner; Konstantinos Zarogoulidis
Journal:  Drug Des Devel Ther       Date:  2014-10-07       Impact factor: 4.162

Review 10.  Maintenance Therapy with Nebulizers in Patients with Stable COPD: Need for Reevaluation.

Authors:  Paul D Terry; Rajiv Dhand
Journal:  Pulm Ther       Date:  2020-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.